Nanobodies are engineered antibodies that have a single domain developed by heavy chains with antigen–binding. These antibodies can be engineered and are suitable for various applications for research, therapeutic development, and medical diagnosis due to their size and single-chain nature. Nanobodies have various interesting applications including research on clinical therapeutics. Nanobodies are extensively used in the field of diagnosis and research, and it plays a crucial role and has great potential in noninvasive in vivo imaging. Nanobodies meet requirements to become a generic imaging tracer and offer benefits in molecular imaging, which leads to an increase in the use of nanobodies.
Market Dynamics
Market players are indulged in research and development activities for advancement of nanobodies for therapeutical treatments, which is expected to drive the growth of the global nanobodies market over the forecast period. For instance, according to an article published on Nature Journal on December 21, 2020, researchers at National Institutes of Health isolated a set of nanobodies against SARS-CoV-2. This nanobody is called NIH-CoVnb-112, which binds and blocks the variant form of SARS-Cov-2 spike protein.
Increasing awareness about early diagnosis as well as treatment is expected to drive the growth of the global nanobodies market over the forecast period. For instance, in October 2020, the Government Royapettah Hospital (GRH) organized an awareness program on breast cancer in India. This enabled to increase early detection, diagnosis, and availability of advanced technologies to improve survival rate of patients. This program aimed to create awareness about breast cancer and prevention at an early stage through early detection to avoid further consequences. By using nanobodies, which work as substitutes for naturally occurring antibodies for cancer treatment, they bind to the antigens on the surface of cancer cells, which helps to detect the cancer cells and block their growth. This can help in reducing the prevalence of cancer.
Key features of the study:
- This report provides an in-depth analysis of global nanobodies market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global nanobodies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Merck KGaA, Sanofi (Ablynx), Alphamab Oncology, Novartis AG, Genscript, Taisho Pharmaceutical Holdings Co., Ltd., Sensei Biotherapeutics, Inc., Cusabio Technology LLC., ChromoTek GmbH, Beroni Group, ExeVir Bio BV, Absolute Antibody, Alpalife (Shenzhen kangti Co., Ltd.), DiosCURE Therapeutics SE, Thermo Fisher Scientific Inc., PerkinElmer Inc. (BioLegend, Inc.), and Abnova Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market
- Global Nanobodies Market, By Product Type :
- Mono specific Nanobodies
- Monovalent Nanobodies
- Multivalent Nanobodies
- Bi-paratopic Nanobodies
- Multi specific Nanobodies
- Fusion Nanobodies
- Global Nanobodies Market, By Application:
- Therapeutic
- Diagnostic
- Global Nanobodies Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Nanobodies Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Merck KGaA
- Sanofi (Ablynx)
- Alphamab Oncology
- Novartis AG
- Genscript
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sensei Biotherapeutics, Inc.
- Cusabio Technology LLC.
- ChromoTek GmbH
- Beroni Group
- ExeVir Bio BV
- Absolute Antibody
- Alpalife (Shenzhen kangti Co., Ltd.)
- DiosCURE Therapeutics SE
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc. (BioLegend, Inc.)
- Abnova Corporation
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Trends
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- 4. Global Nanobodies Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Nanobodies Market, By Product Type, 2020– 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Monovalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Bivalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Bispecific Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Biparatopic Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Multivalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Fusion Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- 6. Global Nanobodies Market, By Therapeutic Area, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Inflammatory and Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- 7. Global Nanobodies Market, By Application, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Diagnostic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- 8. Global Nanobodies Market, By End User, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Mn)
- Segment Trends
- 9. Global Nanobodies Market, By Region, 2020 – 2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- North America
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2020–2032, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2020–2032, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2020–2032, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2020–2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020–2032, (US$ Mn)
- U.S.
- Canada
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- 10. Competitive Landscape
- Company Profiles
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sanofi
- AlpalifeB Inc
- GenScript
- Novartis International AG
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sino Biological, Inc.
- GeneMedi
- Biocytogen
- Abnova Corporation
- NanoTag Biotechnologies
- Avillion LLP
- Capra Science
- Numab Therapeutics
- CUSABIO TECHNOLOGY LLC
- Proteintech Group, Inc.
- GT Biopharma, Inc.
- Confo Therapeutics
- R&D Systems, Inc.
- Abcepta Biotech Ltd. Co.
- Analysts’ Views
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 44 market data tables and 41 figures on “Global Nanobodies Market” – Global forecast to 2032
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook